NCT00482183View on ClinicalTrials.gov

Comparison Between Pioglitazone and SES With type2 DM

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

June 30, 2007

Conditions

Coronary Artery DiseaseType 2 Diabetes Mellitus

Interventions

DRUG

Pioglitazone

All Listed Sponsors

lead

Showa University

OTHER

NCT00482183 - Comparison Between Pioglitazone and SES With type2 DM | Biotech Hunter | Biotech Hunter